DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction.

[1]  A. Partin,et al.  p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape , 2008, The Prostate.

[2]  P. V. van Diest,et al.  Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo , 2008, Molecular Cancer Therapeutics.

[3]  J. Epstein,et al.  A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score. , 2008, The Journal of urology.

[4]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[5]  Robert W Veltri,et al.  Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent , 2008, The Prostate.

[6]  Robert W Veltri,et al.  Prediction of Prostate-Specific Antigen Recurrence in Men with Long-term Follow-up Postprostatectomy Using Quantitative Nuclear Morphometry , 2008, Cancer Epidemiology Biomarkers & Prevention.

[7]  E. Metter,et al.  Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. , 2007, The Journal of urology.

[8]  A. Partin,et al.  Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis , 2007, The Prostate.

[9]  Alan W Partin,et al.  Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. , 2007, Urology.

[10]  Jonathan I. Epstein,et al.  Ability to Predict Metastasis Based On Pathology Findings and Alterations in Nuclear Structure Of Normal-Appearing and Cancer Peripheral Zone Epithelium in the Prostate , 2004, Clinical Cancer Research.

[11]  D. Tindall,et al.  p300 in prostate cancer proliferation and progression. , 2003, Cancer research.

[12]  Hartwig Huland,et al.  Quantitative biopsy pathology for the prediction of pathologically organ‐confined prostate carcinoma , 2003, Cancer.

[13]  D. Chan,et al.  Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men. , 2002, Urology.

[14]  T. Stamey,et al.  Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis. , 2002, Urology.

[15]  R. Veltri,et al.  The role of biopsy pathology, quantitative nuclear morphometry, and biomarkers in the preoperative prediction of prostate cancer staging and prognosis. , 1998, Seminars in urologic oncology.

[16]  D. Bostwick.  Evaluating prostate needle biopsy: Therapeutic and prognostic importance , 1997, CA: a cancer journal for clinicians.

[17]  S. Piantadosi,et al.  Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. , 1997, The American journal of surgical pathology.

[18]  P. Schellhammer,et al.  Results of radical prostatectomy in men with clinically localized prostate cancer. , 1996, JAMA.

[19]  P. Troncoso,et al.  Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading error. , 1995, Urology.

[20]  A. Partin,et al.  Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease. , 1995, The Journal of urology.

[21]  D. Bostwick,et al.  Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. , 1994, The American journal of surgical pathology.

[22]  D. Gleason,et al.  Histologic grading of prostate cancer: a perspective. , 1992, Human pathology.

[23]  J. Mohler,et al.  Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging. , 1991, The Journal of urology.

[24]  A W Partin,et al.  A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. , 1989, The Journal of urology.

[25]  J. Epstein,et al.  Nuclear roundness factor. A predictor of progression in untreated stage A2 prostate cancer , 1984, Cancer.

[26]  J C Eggleston,et al.  A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. , 1982, The Journal of urology.

[27]  S. K. Zaidi,et al.  Combinatorial organization of the transcriptional regulatory machinery in biological control and cancer. , 2005, Advances in enzyme regulation.